Genetics Of Dyslipidemia-..
até
4x
de
R$ 282,18
sem juros
ou R$ 1.072,30
via Pix
Adicionar ao carrinho
Disponibilidade: 45 dias úteis
Estoque: 136 unidades
-
- 1x de R$ 1.128,74 sem juros
- 2x de R$ 564,37 sem juros
- 3x de R$ 376,24 sem juros
- 4x de R$ 282,18 sem juros
-
R$ 1.072,30
-
R$ 1.128,74
Profound mortality rates, due to cardiovascular disease, are a worldwide problem. Cardiovascular disease results from complications of a silent and chronic arterial disease: atherosclerosis. The challenge for the practitioner is adapting diagnostic and therapeutic responses to prevent this common and complex disease.
Dyslipidemia, are disorders of the metabolism of soluble transporters of lipids in extracellular spaces of the human body (including blood), called lipoproteins. They are major cardiovascular risk factors, causally related with atherosclerosis and are themselves multifactorial diseases, resulting from interactions between genetic and environmental factors.
The study of genetic factors has recently taken a new path with the study of DNA as an experimental object. More than fifty genes of lipoprotein metabolism have been identified in both their physiological actions and their contribution to the pathogenesis of human dyslipidemia. The diversity of observations has refined our current knowledge of the control of lipid metabolism and energy homeostasis in living organisms beyond the limits of the cardiovascular system (e.g., brain, immune system, and development). These studies have given way to a shake-up of former phenotypic classifications, distinguishing new entities, defining targeted therapeutic strategies, providing a basis for different patterns of disease distribution in human populations.
Dyslipidemia, are disorders of the metabolism of soluble transporters of lipids in extracellular spaces of the human body (including blood), called lipoproteins. They are major cardiovascular risk factors, causally related with atherosclerosis and are themselves multifactorial diseases, resulting from interactions between genetic and environmental factors.
The study of genetic factors has recently taken a new path with the study of DNA as an experimental object. More than fifty genes of lipoprotein metabolism have been identified in both their physiological actions and their contribution to the pathogenesis of human dyslipidemia. The diversity of observations has refined our current knowledge of the control of lipid metabolism and energy homeostasis in living organisms beyond the limits of the cardiovascular system (e.g., brain, immune system, and development). These studies have given way to a shake-up of former phenotypic classifications, distinguishing new entities, defining targeted therapeutic strategies, providing a basis for different patterns of disease distribution in human populations.
| ISBN | 9781461355939 |
| Autor(a) | Benlian, Pascale |
| Editora | Springer Publishing |
| Ano de edição | 2012 |
| Páginas | 315 |
| Acabamento | Brochura |
| Dimensões | 23,40 X 15,60 |
Produtos relacionados
-
Dyslipidemias In Kidney Disease-..R$ 1.237,10R$ 989,68até 4x de R$ 247,42 sem jurosou R$ 940,20 via Pix20% Desconto -
Stroke Revisited: Dyslipidemia In Stroke-..R$ 1.327,92R$ 1.062,34até 4x de R$ 265,58 sem jurosou R$ 1.009,22 via Pix20% Desconto
Categorias
Pague com
Selos
MYRE EDITORA, COMERCIALIZADORA, IMPORTADORA E DISTRIBUIDORA LTDA - CNPJ: 50.295.718/0001-20 © Todos os direitos reservados. 2026
